MRC-University of Glasgow, Centre for Virus Research, University of Glasgow, Glasgow, UK.
Division of Biomedical Engineering, James Watt School of Engineering, University of Glasgow, Glasgow, UK.
Nat Commun. 2021 Nov 30;12(1):6994. doi: 10.1038/s41467-021-27076-z.
The early diagnosis of active hepatitis C virus (HCV) infection remains a significant barrier to the treatment of the disease and to preventing the associated significant morbidity and mortality seen, worldwide. Current testing is delayed due to the high cost, long turnaround times and high expertise needed in centralised diagnostic laboratories. Here we demonstrate a user-friendly, low-cost pan-genotypic assay, based upon reverse transcriptase loop mediated isothermal amplification (RT-LAMP). We developed a prototype device for point-of-care use, comprising a LAMP amplification chamber and lateral flow nucleic acid detection strips, giving a visually-read, user-friendly result in <40 min. The developed assay fulfils the current guidelines recommended by World Health Organisation and is manufactured at minimal cost using simple, portable equipment. Further development of the diagnostic test will facilitate linkage between disease diagnosis and treatment, greatly improving patient care pathways and reducing loss to follow-up, so assisting in the global elimination strategy.
丙型肝炎病毒(HCV)感染的早期诊断仍然是治疗该病以及预防全球范围内所见相关高发病率和死亡率的重大障碍。由于成本高、周转时间长以及中央诊断实验室需要高度专业知识,目前的检测被推迟。在这里,我们展示了一种基于逆转录酶环介导等温扩增(RT-LAMP)的用户友好、低成本的泛基因型检测方法。我们开发了一种用于即时护理使用的原型设备,包括 LAMP 扩增室和侧流核酸检测条,在 <40 分钟内提供直观、用户友好的结果。该检测方法满足世界卫生组织(WHO)目前推荐的指南,并使用简单、便携的设备以最低成本制造。该诊断测试的进一步开发将促进疾病诊断与治疗之间的联系,极大地改善患者的护理途径并减少失访,从而有助于全球消除策略。